Back to all studies
CompletedNCT00844753

Atomoxetine, Placebo and Parent Management Training in Autism

This study is completed. It focuses on ADHD and currently lists study information in the United States.

ADHD, Autism, ...BehavioralFrom 5 Years to 14 Years
Need help deciding?

Ask HopeStage to review this study with me

Loading the security check...
Study ID: NCT00844753. We help you review the study, but cannot decide medical eligibility.
In plain English

Key information made simple

What is this study testing?

This study is testing whether a study medication may be useful for people experiencing ADHD.

What would participation involve?

Participants may receive a study medication, complete questionnaires or follow-up assessments, attend study visits with the research team. The protocol may also involve randomization, placebo, or a comparison group. The registry lists locations in United States.

Who is it mainly for?

This study appears to be mainly for people with ADHD. Because it may involve minors, a parent or guardian may need to be involved.

What should you check before joining?

Ask about the dose, safety monitoring, and possible side effects, whether there is placebo, randomization, or a comparison group, how many visits or travel steps are needed, what role parents or guardians have in the process.

What to expect

Your next step

The official record suggests in-person participation through a university, with sites including University of Rochester Medical Center, Ohio State University in Columbus, and University of Pittsburgh Medical Center. Participation appears to involve a study treatment together with follow-up visits and routine safety or progress checks. The main fit is usually matching the main diagnosis, while common reasons not to take part include safety concerns that need urgent care first and pregnancy or breastfeeding. This is a later-stage study, which usually means the approach is being followed in broader real-world use.

Before joining

Questions to ask before joining

Study clarity

Things to check before joining

Study start dateOctober 2008
Recruitment status
Completed
Estimated enrollment
Not clearly listed
Sponsor
University of Rochester
Sponsor type
University
Study type
Behavioral
Intervention type
Behavioral / psychological / psychosocial
Study phase
Not clearly listed
Locations
United States
Age range
From 5 Years to 14 Years
Official registry ID
NCT00844753
Official title
Atomoxetine, Placebo and Parent Management Training in Autism
Official source
Official registry link

Want help reviewing this study?

Loading the security check...
Study ID: NCT00844753. We help you review the study, but cannot decide medical eligibility.
In practice

For you

Taking part may help test a support approach in real life.

It requires regular visits and structured follow-up.

Requires travel, with in-person participation in United States.

Important

Not medical advice

Information from public sources. Are you the study sponsor? Contact us to update this page: hi@hopestage.com

FAQ

Questions about this study

What is this study trying to understand?

This study is exploring psychotherapy or therapy for people with adhd. Participants may complete study visits, assessments, or follow-up activities defined by the research team. Direct benefit is not guaranteed. The detailed objective is not always clearly listed in the public registry; the study team can confirm.

What is a behavioral study?

This appears to be a behavioral / psychological / psychosocial study. Phase is mainly useful to check for medication studies and some device studies.

Who might this study be for?

This study may concern people with adhd; age range: From 5 Years to 14 Years. The criteria appear fairly specific, but you should not assume you are eligible. The study team must confirm diagnosis, age, exclusions, available locations, and next steps.

Does a loved one or caregiver need to be involved?

The public registry appears to mention a loved one, caregiver, or family involvement. Ask whether that person must participate, provide information, attend visits, or simply be available if needed. The study team must confirm what is required.

Could this study affect my mood, habits, motivation, or stress?

Behavioral studies can involve habits, emotions, motivation, stress, sleep, or ways of thinking. Ask whether the intervention could affect your mood or stress, and who to contact if you feel worse. For any mental health study, also ask who to contact if you feel worse, whether participation may affect current treatment, whether you can stop, and who confirms eligibility.

Will I need to travel or attend in-person visits?

The listed study locations suggest that at least part of participation may involve a physical site. Ask which sites are open, how many visits are expected, whether any steps can be done remotely, and whether travel costs or compensation are listed.

Who is behind this study?

This study is sponsored by University of Rochester, which appears to be a university. If available, it can be useful to check the sponsor website, collaborators, investigator affiliation, and the official registry before deciding. HopeStage does not judge the quality of a sponsor or researcher, but helps you identify what to verify.

Can I still join this study?

The registry indicates that this study is completed. It may still be useful for understanding the research, but you are unlikely to be able to join.

Explore other studies

Want to find a study that may fit you better?

Answer a few simple questions to explore HopeStage studies by condition, country, and situation.

Find a study that may fit me
Atomoxetine, Placebo and Parent Management Training in Autism — ADHD Clinical Trial | HopeStage